Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|November 6, 2009
Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patientsM Mego, U De Giorgi, K Broglio, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 2, 2016
Immediate and intermediate-term results of optical coherence tomography guided atherectomy in the treatment of peripheral arterial disease: Initial results from the VISION trialIan Cawich, Andre R M Paixao, Konstantinos Marmagkiolis, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 13, 2022
Fatal myocarditis after the first dose of nivolumabE Zomborska, S Kasperova, J Slopovsky, et al.
Investigational New Drugs|June 2, 2019
Phase II study of avelumab in multiple relapsed/refractory germ cell cancerM Mego, D Svetlovska, M Chovanec, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2005
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II studyM Mego, R Koncekova, E Mikuskova, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2017
Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-studyM Mego, C Manichanh, A Accarino, et al.
Neoplasma|April 24, 2007
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II studyJ Mardiak, T Sálek, Z Sycová-Milá, et al.
Investigational New Drugs|May 30, 2021
Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trialM Mego, D Svetlovska, M Reckova, et al.
Neoplasma|April 1, 2010
Treatment of newly diagnosed patients with acute promyelocytic leukemia with modified spanish treatment protocolI Oravcova, B Czako, E Demeckova, et al.
BMC Cancer|August 5, 2016
Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situZ Cierna, M Mego, I Jurisica, et al.
Pageof 7